Abraham Ludomirski, Director at Recro Pharma, Inc. (REPH), sold 11,082 shares at $9.00 ($100K) on 2015-11-23, disclosed to the SEC on 2016-05-23.
Open-market sale of $100k REPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RWLK | SELL | 2016-06-06 | $194K | — | Filing → |
| REPH | SELL | 2016-05-23 | $701K | — | Filing → |
| REPH | SELL | 2016-05-23 | $61K | — | Filing → |